📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial (2023)

First Author: Heerspink H

Attributed to: Impact of combined iodine and bromine release on the Arctic atmosphere (COBRA). funded by NERC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/s0140-6736(23)00569-x

PubMed Identifier: 37015244

Publication URI: http://europepmc.org/abstract/MED/37015244

Type: Journal Article/Review

Parent Publication: The Lancet

Issue: 10388

ISSN: 0140-6736